Adjusted earnings per share for the quarter to June 29 fell to $2.77 from $2.82 in the same period a year ago, and topped the average analyst EPS estimate compiled by FactSet of $2.68.

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Calpers is switching to CVS from OptumRx, which is part of UnitedHealth Group. The California pension fund said it chose CVS Caremark because it offered more affordable benefits than other vendors.

There are many ways companies can manipulate their reported profits. Fudging sales (also known as revenue) is more difficult.

Fort Sheridan Advisors dramatically reduced its CVS Health stake by over 60%, selling 5,130 shares in the first quarter.

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded ...

Nichols & Pratt Advisers sold 7,627 CVS Health shares in Q1, lowering its stake by 6.9%, SEC filings show. The firm now holds ...

June was highly successful for U.S. stock markets. The three major stock indexes ... for current-year earnings has improved 0 ...

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, a high estimate of $84.00, and a low estimate of $71.00. This upward trend ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock ...

CVS Health Corporation (NYSE:CVS) is a health solutions company that operates in four segments: healthcare benefits, health services, pharmacy and consumer wellness, and corporate/other.